Argenx Se (ARGX) Gross Profit (2022 - 2026)

Argenx Se (ARGX) posted Gross Profit of $1.2 billion for Q1 2026, up 3.61% on a QoQ basis from $1.1 billion in Q4 2025, and up 66.01% year-over-year from $709.0 million in Q1 2025.

Argenx Se (ARGX) Gross Profit (2022 - 2026) Analysis & Trends

Argenx Se's Gross Profit history runs 5 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

  • Quarterly Gross Profit rose 66.01% year-over-year to $1.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 billion (up 80.26% YoY) and the FY2025 annual result came in at $3.7 billion, up 88.94% from the prior year.
  • Gross Profit was $1.2 billion for Q1 2026 at Argenx Se, up from $1.1 billion in the prior quarter.
  • Across five years, Gross Profit topped out at $1.2 billion in Q1 2026 and bottomed at $19.8 million in Q1 2022.
  • A 5-year average of $487.1 million and a median of $355.1 million in 2024 frame the typical range for Gross Profit.
  • Annual changes were most pronounced in 2023 — Gross Profit jumped 908.98% — and 2026, when it jumped 66.01%.
  • Argenx Se's Gross Profit stood at $160.6 million in 2022, then soared by 108.5% to $334.9 million in 2023, then surged by 98.38% to $664.3 million in 2024, then jumped by 71.01% to $1.1 billion in 2025, then rose by 3.61% to $1.2 billion in 2026.
  • Business Quant data shows ARGX's Gross Profit at $1.2 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.0 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.18 Bn
Mar 31, 2026 1.18 Bn
Dec 31, 2025 1.14 Bn
Dec 31, 2025 1.14 Bn
Sep 30, 2025 1.02 Bn
Sep 30, 2025 1.02 Bn
Jun 30, 2025 837.85 Mn
Jun 30, 2025 837.85 Mn
Mar 31, 2025 709.00 Mn
Mar 31, 2025 709.00 Mn
Dec 31, 2024 664.31 Mn
Dec 31, 2024 664.31 Mn
Sep 30, 2024 513.93 Mn
Sep 30, 2024 513.93 Mn
Jun 30, 2024 425.25 Mn
Jun 30, 2024 425.25 Mn
Mar 31, 2024 355.11 Mn
Mar 31, 2024 355.11 Mn
Dec 31, 2023 334.87 Mn
Dec 31, 2023 334.87 Mn